Compound red yeast capsule
A compound red yeast yeast capsule and red yeast rice technology, applied in capsule delivery, pharmaceutical formulation, food science and other directions, can solve the problems of human body side effects, gastrointestinal reactions, increased liver and kidney burden, etc., achieve good lipid-lowering effect, guarantee Safe and good lipid-lowering effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0020] A compound red yeast rice capsule is prepared by the following method:
[0021] Content preparation: Take 66kg of red yeast rice powder, 11.4kg of ginkgo leaf extract, and 22.6kg of eucommia leaf extract. After mixing the above three fine powders in a mixer, fill them into No. 0 empty capsules, each capsule Pack 0.3g.
[0022] The lovastatin in the red yeast rice is 2.5% of the red yeast rice powder obtained through natural fermentation.
[0023] The ginkgo biloba extract meets the regulations of the first part of the 2010 edition of the People's Republic of China Pharmacopoeia.
[0024] The eucommia ulmoides leaf extract is a refined eucommia ulmoides leaf extract powder with a chlorogenic acid content of 40%.
[0025] The total weight of the contents is 100kg, which can be made into 333,333 capsules, each capsule is 300mg, the main functional ingredient lovastatin content is 1.65%, and each capsule contains 4.95mg pure lovastatin.
Embodiment 2
[0027] A compound red yeast rice capsule is prepared by the following method:
[0028] Content preparation: Take 30kg of red yeast rice powder, 12kg of ginkgo leaf extract, 58kg of eucommia leaf extract, mix the above three fine powders evenly in a mixer, and fill them in No. 0 empty capsules, each capsule contains 0.3 g.
[0029] The lovastatin content in the red yeast rice is 4% of the red yeast rice powder obtained by pure natural fermentation.
[0030] The ginkgo biloba extract meets the regulations of the first part of the 2010 edition of the People's Republic of China Pharmacopoeia.
[0031] The eucommia leaf extract is a refined eucommia leaf extract powder with a chlorogenic acid content of 20%.
[0032] The total weight of the contents is 100kg, which can be made into 333,333 capsules, each capsule is 300mg, the main functional ingredient lovastatin content is 1.20%, and each capsule contains 3.60mg pure lovastatin.
Embodiment 3
[0034] A compound red yeast rice capsule is prepared by the following method:
[0035] Content preparation: Take 85kg of red yeast rice powder, 1kg of ginkgo leaf extract, 14kg of eucommia leaf extract, mix the above three fine powders in a mixer, and fill them into No. 0 empty capsules, each capsule contains 0.3 g.
[0036] The red yeast rice is a powder of red yeast rice obtained by fermentation with lovastatin content of 0.5% by mass.
[0037] The ginkgo biloba extract meets the regulations of the first part of the 2010 edition of the People's Republic of China Pharmacopoeia.
[0038] The eucommia leaf extract is a refined eucommia leaf extract powder with a chlorogenic acid content of 50%.
[0039] The total weight of the contents is 100kg, which can be made into 333,333 capsules, each capsule is 300mg, the main functional ingredient lovastatin is 0.425% by mass, and each capsule contains 1.275mg pure lovastatin.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com